Undisclosed conflict of interest in the FDA review process

A report from the WSJ this week detailed the fact that FDA reviewers had significant and undisclosed financial ties to industry. I found this discovery remarkable, especially the undisclosed part. But perhaps more remarkable was the lack of reaction it created. The article has only 39 comments, paltry numbers of Tweets and FB shares and… Continue reading Undisclosed conflict of interest in the FDA review process